Abstract
Dissolution testing is a critical enabler for formulation process development as well as determination of product quality at release and on stability for solid oral dosage forms. In the pharmaceutical industry worldwide, this type of test is performed in the range of millions annually. We developed an improved chromatographic protocol combining the utilization of smaller internal diameter (i.d.) columns, superficially porous column technology, injection cycle time for gradient re-equilibration, system dwell volume understanding, and basic separation concepts for optimization as a greener, faster, yet robust way to conduct dissolution testing. Comparing this approach to standard analysis using a conventional approach, this methodology provides 70–80% reduction in solvent consumption and waste generation, as well as run times with equivalent accuracy, precision, and robustness. Feasibility of this approach was demonstrated by applying it to multiple drug products and those head-to-head comparisons showed that dissolution profiles and overall variability are comparable to those obtained by the conventional chromatographic approaches.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.